Qube Research & Technologies (QRT)
TRDA icon

Qube Research & Technologies (QRT)’s Entrada Therapeutics TRDA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TRDA Stock Details TRDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1M Sell
87,453
-88,565
-50% -$1.01M ﹤0.01% 2444
2025
Q4 		$1.81M Sell
176,018
-111,855
-39% -$943K ﹤0.01% 2308
2025
Q3 		$1.67M Buy
287,873
+154,143
+115% +$902K ﹤0.01% 2317
2025
Q2 		$899K Buy
133,730
+108,737
+435% +$875K ﹤0.01% 2503
2025
Q1 		$226K Buy
+24,993
New +$311K ﹤0.01% 2833
2023
Q2 		– Sell
-38,782
Closed -$562K – 3021
2023
Q1 		$562K Buy
38,782
+22,000
+131% +$294K ﹤0.01% 1525
2022
Q4 		$227K Buy
+16,782
New +$294K ﹤0.01% 1761

Other funds holding TRDA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return